The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Canada is poised to lose its measles elimination status after nearly three decades, and public health experts fear outbreaks ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

Canada eliminated measles in 1998. The U.S. followed two years later, in 2000. There are multiple criteria for losing an ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

Interprovincial credential recognition, funding agreements, mental health and addiction issues, and vaccination programs are ...

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of ...

If current trends continue, North America could soon become a hotspot for permanent measles transmission. Canada could lose ...

The advisory is the latest pushback on claims raised by U.S. President Donald Trump and his top political health appointees this week linking acetaminophen to autism.

A Kelowna woman who has been selling ivermectin online as a treatment for cancer has had her business raided by Health Canada.